Trade Summary

1 week ago, Harmon Cyrus, serving as Dir at Olema Pharmaceuticals, Inc. (OLMA), sold 2,881 shares at $28.53 per share, for a total transaction value of $82,195.00. Following this transaction, Harmon Cyrus now holds 858,287 shares of OLMA.

The trade was executed on Monday, December 22, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 7 days after the trade was made.

Olema Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.